Matches in Wikidata for { <http://www.wikidata.org/entity/Q94151196> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q94151196 description "article scientifique publié en 2018" @default.
- Q94151196 description "wetenschappelijk artikel" @default.
- Q94151196 description "наукова стаття" @default.
- Q94151196 name "CBMT-17. NOVEL APPROACH OF UTILISING SERUM/PLASMA EV AND CELL-FREE RNA FOR TREATMENT MONITORING IN GLIOBLASTOMA PATIENTS" @default.
- Q94151196 name "CBMT-17. NOVEL APPROACH OF UTILISING SERUM/PLASMA EV AND CELL-FREE RNA FOR TREATMENT MONITORING IN GLIOBLASTOMA PATIENTS" @default.
- Q94151196 type Item @default.
- Q94151196 label "CBMT-17. NOVEL APPROACH OF UTILISING SERUM/PLASMA EV AND CELL-FREE RNA FOR TREATMENT MONITORING IN GLIOBLASTOMA PATIENTS" @default.
- Q94151196 label "CBMT-17. NOVEL APPROACH OF UTILISING SERUM/PLASMA EV AND CELL-FREE RNA FOR TREATMENT MONITORING IN GLIOBLASTOMA PATIENTS" @default.
- Q94151196 prefLabel "CBMT-17. NOVEL APPROACH OF UTILISING SERUM/PLASMA EV AND CELL-FREE RNA FOR TREATMENT MONITORING IN GLIOBLASTOMA PATIENTS" @default.
- Q94151196 prefLabel "CBMT-17. NOVEL APPROACH OF UTILISING SERUM/PLASMA EV AND CELL-FREE RNA FOR TREATMENT MONITORING IN GLIOBLASTOMA PATIENTS" @default.
- Q94151196 P1433 Q94151196-1E87F57F-BA31-44DA-8D64-782417B60D02 @default.
- Q94151196 P1476 Q94151196-6EC11DBC-BE71-45F9-9E45-53722C9DFA39 @default.
- Q94151196 P2093 Q94151196-202AF273-2045-4688-8FD2-9617E5DAB276 @default.
- Q94151196 P2093 Q94151196-226908B1-D09E-479F-8C47-AE04EFA89C2A @default.
- Q94151196 P2093 Q94151196-3987272B-2065-4653-AC74-9AE8195E595F @default.
- Q94151196 P2093 Q94151196-A4AC16BB-2D97-4167-B0B4-B23A83E53BFC @default.
- Q94151196 P2093 Q94151196-B266A642-6359-408D-B25C-9FDB51CEBAEF @default.
- Q94151196 P2093 Q94151196-C9302C42-0DD1-4BEB-9BB5-9CE17ABD2540 @default.
- Q94151196 P2093 Q94151196-E53D599F-830F-4F01-AAC0-64E995B57E93 @default.
- Q94151196 P304 Q94151196-1FF0CE9A-05B6-4ACA-92AA-7A8427FD5EB0 @default.
- Q94151196 P31 Q94151196-C3E2CDB3-4484-4EF0-B2E5-8CA8C58C21EB @default.
- Q94151196 P356 Q94151196-FEC79944-0C76-401A-8E0B-0F6AB5091C14 @default.
- Q94151196 P433 Q94151196-5E063325-06DD-45CB-8039-0BA4AE0A855E @default.
- Q94151196 P478 Q94151196-21964C79-EE89-46E8-943C-FD590E69C1E1 @default.
- Q94151196 P577 Q94151196-148DF926-AF93-45B2-A264-C89A618C763E @default.
- Q94151196 P921 Q94151196-DA0214A8-B61F-4C39-A5FF-3D1210406CB6 @default.
- Q94151196 P932 Q94151196-6954532C-909C-4CF2-A9D6-A8575972665A @default.
- Q94151196 P356 NOY148.136 @default.
- Q94151196 P1433 Q15724471 @default.
- Q94151196 P1476 "CBMT-17. NOVEL APPROACH OF UTILISING SERUM/PLASMA EV AND CELL-FREE RNA FOR TREATMENT MONITORING IN GLIOBLASTOMA PATIENTS" @default.
- Q94151196 P2093 "Björn Scheffler" @default.
- Q94151196 P2093 "Christoph Coch" @default.
- Q94151196 P2093 "Hartmann Gunther" @default.
- Q94151196 P2093 "Katrin Reiners" @default.
- Q94151196 P2093 "Martin Glas" @default.
- Q94151196 P2093 "Theophilos Tzaridis" @default.
- Q94151196 P2093 "Ulrich Herrlinger" @default.
- Q94151196 P304 "vi35-vi36" @default.
- Q94151196 P31 Q13442814 @default.
- Q94151196 P356 "10.1093/NEUONC/NOY148.136" @default.
- Q94151196 P433 "Suppl 6" @default.
- Q94151196 P478 "20" @default.
- Q94151196 P577 "2018-11-05T00:00:00Z" @default.
- Q94151196 P921 Q282142 @default.
- Q94151196 P932 "6217007" @default.